Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
Hohe Gewinnwachstumsrate
Das Nettoeinkommen des Unternehmens führt die Branche an, das letzte Jahres Einkommen betrug insgesamt 701.20M USD.
Unterbewertet
Die aktuelle PE1 des Unternehmens liegt bei -15.322, im niedrigen 3-Jahres-Perzentilbereich.
Institutionelle Verkäufe
Die neuesten institutionellen Bestände sind 45.51M Aktien, was einen Rückgang von 17.70% im Vergleich zum Vorquartal darstellt.
Gehalten von Diamond Hill Capital
Star-Investor Diamond Hill Capital1 hält 324.32K2 Aktien dieses Unternehmens.
Niedrigere Marktaktivität
Das Unternehmen hat weniger Investoreninteresse, mit einem 20-Tage-Umsatzverhältnis von 0.97.